Quidel Corporation is a diagnostics & research business based in the US. Quidel Corporation shares (QDEL) are listed on the NASDAQ and all prices are listed in US Dollars. Quidel Corporation employs 1,370 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Quidel Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – QDEL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Quidel Corporation stock price (NASDAQ: QDEL)Use our graph to track the performance of QDEL stocks over time.
Quidel Corporation shares at a glance
|Latest market close||$118.11|
|52-week range||$103.31 - $306.72|
|50-day moving average||$124.30|
|200-day moving average||$146.12|
|Wall St. target price||$146.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$21.74|
Buy Quidel Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Quidel Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Quidel Corporation price performance over time
|1 week (2021-07-25)||N/A|
|1 month (2021-07-02)||-5.73%|
|3 months (2021-05-05)||4.99%|
|6 months (2021-02-01)||N/A|
|1 year (2020-08-01)||N/A|
|2 years (2019-08-01)||N/A|
|3 years (2018-08-01)||N/A|
|5 years (2016-08-01)||N/A|
Is Quidel Corporation under- or over-valued?
Valuing Quidel Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quidel Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Quidel Corporation's P/E ratio
Quidel Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Quidel Corporation shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Quidel Corporation's PEG ratio
Quidel Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.19. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quidel Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quidel Corporation's EBITDA
Quidel Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.3 billion.
The EBITDA is a measure of a Quidel Corporation's overall financial performance and is widely used to measure a its profitability.
Quidel Corporation financials
|Revenue TTM||$1.9 billion|
|Operating margin TTM||66.41%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||50.46%|
|Return on equity TTM||90.52%|
|Market capitalisation||$6.1 billion|
TTM: trailing 12 months
Shorting Quidel Corporation shares
There are currently 5.7 million Quidel Corporation shares held short by investors – that's known as Quidel Corporation's "short interest". This figure is 15.7% up from 4.9 million last month.
There are a few different ways that this level of interest in shorting Quidel Corporation shares can be evaluated.
Quidel Corporation's "short interest ratio" (SIR)
Quidel Corporation's "short interest ratio" (SIR) is the quantity of Quidel Corporation shares currently shorted divided by the average quantity of Quidel Corporation shares traded daily (recently around 711210.81761006). Quidel Corporation's SIR currently stands at 7.95. In other words for every 100,000 Quidel Corporation shares traded daily on the market, roughly 7950 shares are currently held short.
However Quidel Corporation's short interest can also be evaluated against the total number of Quidel Corporation shares, or, against the total number of tradable Quidel Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Quidel Corporation's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Quidel Corporation shares in existence, roughly 130 shares are currently held short) or 0.1465% of the tradable shares (for every 100,000 tradable Quidel Corporation shares, roughly 147 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Quidel Corporation.
Find out more about how you can short Quidel Corporation stock.
Quidel Corporation share dividends
We're not expecting Quidel Corporation to pay a dividend over the next 12 months.
Quidel Corporation share price volatility
Over the last 12 months, Quidel Corporation's shares have ranged in value from as little as $103.31 up to $306.7236. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quidel Corporation's is 0. This would suggest that Quidel Corporation's shares are less volatile than average (for this exchange).
Quidel Corporation overview
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.
Stocks similar to Quidel Corporation
Quidel Corporation in the news
Quidel (QDEL) to Report Q2 Earnings: What's in the Offing?
Earnings Preview: Quidel (QDEL) Q2 Earnings Expected to Decline
3 Reasons I Gave Up on Quidel
Frequently asked questionsWhat percentage of Quidel Corporation is owned by insiders or institutions?
Currently 11.937% of Quidel Corporation shares are held by insiders and 88.933% by institutions. How many people work for Quidel Corporation?
Latest data suggests 1,370 work at Quidel Corporation. When does the fiscal year end for Quidel Corporation?
Quidel Corporation's fiscal year ends in December. Where is Quidel Corporation based?
Quidel Corporation's address is: 9975 Summers Ridge Road, San Diego, CA, United States, 92121 What is Quidel Corporation's ISIN number?
Quidel Corporation's international securities identification number is: US74838J1016 What is Quidel Corporation's CUSIP number?
Quidel Corporation's Committee on Uniform Securities Identification Procedures number is: 74838J101
More guides on Finder
How to buy Chobani stock when it goes public
Everything we know about the Chobani IPO, plus information on how to buy in.
How to buy Stronghold Digital Mining (SDIG) stock when it goes public
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
How to buy ROX Financial LP (ROXA) stock when it goes public
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
Ask an Expert